Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
The Journal of Rheumatology|February 3, 2019
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.Journal of Cutaneous Medicine and Surgery|November 23, 2018
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive TherapiesKim A Papp, Boulos Haraoui, Deepali Kumar, et al.Journal of the Canadian Association of Gastroenterology|October 17, 2019
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.Arthritis Care & Research|December 2, 2017
Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort StudyElizabeth Schulman, Susan J Bartlett, Orit Schieir, et al.Plos One|August 25, 2015
Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH)Cheryl Barnabe, Ye Sun, Gilles Boire, et al.ACR Open Rheumatology|February 18, 2025
Chronicity of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno-Oncology DatabaseAlexandra Ladouceur, Shahin Jamal, Alexandra Saltman, et al.Cancer Immunology, Immunotherapy : CII|January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-OncologySabrina Hoa, Linda Laaouad, Janet Roberts, et al.Lancet Regional Health. Americas|March 29, 2022
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort studySophie Stukas, George Goshua, Angus Kinkade, et al.The Journal of Rheumatology|July 15, 2022
Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic DrugsGlen S Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, et al.RMD Open|June 3, 2016
Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain SetVivian P Bykerk, Clifton O Bingham, Ernest H Choy, et al.Pageof 5